Publication | Closed Access

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseRheumatic DiseasesImmunologyPathologyAutoimmunityAutoantibodiesInflammatory Rheumatic DiseaseMedicineInflammatory DiseaseInflammatory ArthritisRheumatoid ArthritisInflammatory Components